Collegium Pharmaceutical (COLL) Net Shares Issued and Repurchased (2015 - 2025)

Collegium Pharmaceutical has reported Net Shares Issued and Repurchased for 11 years, with the latest figure at $92284.0 in Q1 2025.

• On a quarterly basis, Net Shares Issued and Repurchased changed N/A year-over-year to $92284.0 in Q1 2025; TTM through Mar 2025 was $92284.0, a N/A change from a year earlier, with the FY2024 full-year figure at $338101.0, up 63.91% from the prior year.
• Net Shares Issued and Repurchased was $92284.0 for Q1 2025 at Collegium Pharmaceutical, down from $338101.0 in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $550626.0 in Q4 2021, with the low at $63000.0 in Q1 2021.
• Average Net Shares Issued and Repurchased over 5 years is $231287.3, with a median of $171856.5 recorded in 2022.
• The sharpest annual moves came in 2021 and 2022: Net Shares Issued and Repurchased sank 89.04% in 2021, then surged 118.16% in 2022.
• Over 5 years, Net Shares Issued and Repurchased stood at $550626.0 in 2021, then plunged by 75.04% to $137440.0 in 2022, then jumped by 50.08% to $206273.0 in 2023, then soared by 63.91% to $338101.0 in 2024, then tumbled by 72.71% to $92284.0 in 2025.
• The last three Net Shares Issued and Repurchased figures came in at $92284.0 (Q1 2025), $338101.0 (Q4 2024), and $206273.0 (Q4 2023), per Business Quant data.